The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
<h4>Background</h4>Neuropsychiatric conditions comprise 14% of the global burden of disease and 30% of all noncommunicable disease. Despite the existence of cost-effective interventions, including administration of psychotropic medicines, the number of persons who remain untreated is as...
Saved in:
Main Authors: | Ryan McBain, Daniel J Norton, Jodi Morris, M Taghi Yasamy, Theresa S Betancourt |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/c068df070de74b75a6fb2dbfe8245a62 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving Access & Use of Psychotropic Medicines
by: World Health Organization -
Speech and language therapy education in low middle income countries: the what, the where and the who
by: A. Rupert, et al.
Published: (2015) -
Health System Predictors of Access to Maternal Health Medicines in Low and Middle Income Countries
by: C.E. Nnorom
Published: (2017) -
COULD AN INCREASE IN EDUCATION RAISE INCOME INEQUALITY ?: EVIDENCE FOR LATIN AMERICA
by: Battistón,Diego, et al.
Published: (2014) -
PSYCHOTROPIC PROPERTIES OF REMEDY “ADAPTOPHYT-15”
by: M. V. Baldandorzhiyeva, et al.
Published: (2012)